SEC 13F Intelligence

Temasek Holdings (Private) Ltd / VIR

Temasek Holdings (Private) Ltd’s Vir Biotechnology Inc Position

Does Temasek Holdings (Private) Ltd own Vir Biotechnology Inc (VIR)? Not currently — the last reported position was 5.13M shares worth $126M in Q2 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$126M
Q2 2023
Shares
5.13M
% of Portfolio
+0.73%
Quarters Held
15
position exited

Position History VIR

Reported value by quarter
Q4 ’19: $69MQ4 ’19Q1 ’20: $188MQ2 ’20: $225MQ2 ’20Q3 ’20: $189MQ4 ’20: $147MQ4 ’20Q1 ’21: $283MQ2 ’21: $265MQ2 ’21Q3 ’21: $265MQ4 ’21: $232MQ4 ’21Q1 ’22: $144MQ2 ’22: $143MQ2 ’22Q3 ’22: $116MQ4 ’22: $145MQ4 ’22Q1 ’23: $116MQ2 ’23: $126MQ2 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20235.13M$126M+0.73%
Q1 20236.04M$116M+0.70%
Q4 20225.71M$145M+0.85%
Q3 20226.04M$116M+0.70%
Q2 20225.60M$143M+0.78%
Q1 20225.60M$144M+0.61%
Q4 20215.54M$232M+0.84%
Q3 20215.61M$265M+0.89%
Q2 20215.61M$265M+0.77%
Q1 20215.52M$283M+1.11%
Q4 20205.50M$147M+0.63%
Q3 20205.50M$189M+0.96%
Q2 20205.50M$225M+1.35%
Q1 20205.50M$188M+1.39%
Q4 20195.50M$69M+0.45%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Temasek Holdings (Private) Ltd’s full portfolio or all institutional holders of VIR.